...
首页> 外文期刊>Cancer Cell >CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis
【24h】

CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis

机译:CARM1对于骨髓性白血病,对于正常血缺乏症来说是必不可少的

获取原文
获取原文并翻译 | 示例
           

摘要

Chromatin-modifying enzymes, and specifically the protein arginine methyltransferases (PRMTs), have emerged as important targets in cancer. Here, we investigated the role of CARM1 in normal and malignant hematopoiesis. Using conditional knockout mice, we show that loss of CARM1 has little effect on normal hematopoiesis. Strikingly, knockout of Carm1 abrogates both the initiation and maintenance of acute myeloid leukemia (AML) driven by oncogenic transcription factors. We show that CARM1 knockdown impairs cell-cycle progression, promotes myeloid differentiation, and ultimately induces apoptosis. Finally, we utilize a selective, small-molecule inhibitor of CARM1 to validate the efficacy of CARM1 inhibition in leukemia cells in vitro and in vivo. Collectively, this work suggests that targeting CARM1 may be an effective therapeutic strategy for AML.
机译:染色质修饰酶,特别是蛋白质精氨酸甲基转移酶(PRMT),已成为癌症的重要靶点。在这里,我们研究了CARM1在正常和恶性造血中的作用。使用条件敲除小鼠,我们发现CARM1的缺失对正常造血几乎没有影响。引人注目的是,Carm1基因的敲除消除了由致癌转录因子驱动的急性髓系白血病(AML)的发生和维持。我们发现CARM1基因敲除会损害细胞周期进程,促进髓系分化,并最终诱导细胞凋亡。最后,我们利用选择性小分子CARM1抑制剂在体外和体内验证CARM1抑制白血病细胞的效果。总之,这项研究表明,针对CARM1可能是AML的一种有效治疗策略。

著录项

  • 来源
    《Cancer Cell》 |2018年第6期|共22页
  • 作者单位

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Dept Mol &

    Cellular Pharmacol Miami FL 33136 USA;

    Univ Miami Dept Mol &

    Cellular Pharmacol Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Mem Sloan Kettering Canc Ctr New York NY 10065 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    GlaxoSmithKline Oncol R&

    D Canc Epigenet Discovery Performance Unit 1250 S Collegeville Rd;

    GlaxoSmithKline Oncol R&

    D Canc Epigenet Discovery Performance Unit 1250 S Collegeville Rd;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Harvard Med Sch Harvard Stem Cell Inst Boston MA 02115 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

    Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号